These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 32266849)

  • 1. Not just 'immunity': how the microbiota can reshape our approach to cancer immunotherapy.
    Boem F; Nannini G; Amedei A
    Immunotherapy; 2020 Apr; 12(6):407-416. PubMed ID: 32266849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revealing the therapeutic properties of gut microbiota: transforming cancer immunotherapy from basic to clinical approaches.
    Hazra R; Chattopadhyay S; Mallick A; Gayen S; Roy S
    Med Oncol; 2024 Jun; 41(7):175. PubMed ID: 38874788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
    Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
    Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
    Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
    Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
    Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome bacterial influencers of host immunity and response to immunotherapy.
    Yousefi Y; Baines KJ; Maleki Vareki S
    Cell Rep Med; 2024 Apr; 5(4):101487. PubMed ID: 38547865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy.
    Yin Q; Ni JJ; Ying JE
    Immun Inflamm Dis; 2024 Jul; 12(7):e1263. PubMed ID: 39031507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the gut microbiome with cancer immunotherapy.
    Nomura M
    Int J Clin Oncol; 2023 Mar; 28(3):347-353. PubMed ID: 35568746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of the gut microbiota in immune responses and cancer immunotherapy.
    Li Z; Xiong W; Liang Z; Wang J; Zeng Z; Kołat D; Li X; Zhou D; Xu X; Zhao L
    J Hematol Oncol; 2024 May; 17(1):33. PubMed ID: 38745196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota and Immune Checkpoint Inhibitors-Based Immunotherapy.
    Tian M; Zhang S; Tseng Y; Shen X; Dong L; Xue R
    Anticancer Agents Med Chem; 2022; 22(7):1244-1256. PubMed ID: 34229597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome and cancer treatment: Are we ready to apply in clinics?
    Chan SL
    Prog Mol Biol Transl Sci; 2020; 171():301-308. PubMed ID: 32475526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging role of microbiota in immunomodulation and cancer immunotherapy.
    Singh RP; Bashir H; Kumar R
    Semin Cancer Biol; 2021 May; 70():37-52. PubMed ID: 32580024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy.
    Yang Y; An Y; Dong Y; Chu Q; Wei J; Wang B; Cao H
    EBioMedicine; 2024 Feb; 100():104967. PubMed ID: 38241975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
    Lau HCH; Sung JJ; Yu J
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome in cancer: An exploration of carcinogenesis, immune responses and immunotherapy.
    Zhou P; Hu Y; Wang X; Shen L; Liao X; Zhu Y; Yu J; Zhao F; Zhou Y; Shen H; Li J
    Front Immunol; 2022; 13():877939. PubMed ID: 36003378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.